Article

newatlas.com on 2018-04-16 04:28

Promising cancer drug aces human clinical trials

A new cancer drug known as BLU-667 has moved through phase I human trials, and the results are promising. Taken orally, the drug targets what are ...

Related news

Anti-aging compound from pomegranates proves promising in human clinical trials newatlas.com
Scientists discover why a promising cancer drug failed in clinical trials – and how to fix it newatlas.com
Promising B.C. prostate cancer drug approved for clinical trials theprovince.com
North America , Richmond , British Columbia , Canada
"Unprecedented achievement” enables clinical trials of promising anti-cancer molecule newatlas.com
Phase 1 , Japan
Promising ovarian cancer drug in phase 3 clinical trials newatlas.com
Trojan
China’s promising pancreatic cancer treatment to start clinical trials after showing ‘superior efficacy’South China Morning Post
Hong Kong , China
Promising Alzheimer's drug fails in clinical trials CNN
Stephenson leads cancer clinical trials journalrecord.com
Cancer vaccines enter clinical trials Philly.com
O'fallon , Mayo Clinic
Tampa's Morphogenesis gets the go-ahead to expand human cancer clinical trials bizjournals.com
Tampa
The Human Face of Clinical Trials Forbes
Product Liability Insurance for Human Clinical Trials jdsupra.com
Australia , Canada , Asia , Latin America , Europe
Covaxin: Human clinical trials of vaccine begin The Times of India
UNM Hospital clinical trials benefiting cancer patients KOB 4
Recurrent Ovarian Cancer and Clinical Trials curated.tncontentexchange.com
Orchard Lake
Too few adults in cancer clinical trials nwaonline.com
Canada , United States , Lexington , Maryland , Baltimore
A Cancer Patient’s Guide to Clinical Trials ProPublica
Melanoma Cancer Vaccine Nearing Advanced Clinical Trials westsidetoday.com
UH clinical trials focus on breast cancer staradvertiser.com
islands